Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -82.13% | -61.60% | -21.65% | -7.20% | 18.33% |
| Total Depreciation and Amortization | -- | 300.00% | -91.43% | -97.44% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 429.73% | 405.37% | 241.13% | 3.80% | -32.48% |
| Change in Net Operating Assets | -18.41% | -322.59% | 270.29% | 143.10% | 69.44% |
| Cash from Operations | -70.92% | -67.93% | -12.19% | 10.36% | 21.19% |
| Capital Expenditure | -16.67% | -233.33% | -1,100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -66.67% | -66.67% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -233.33% | -216.67% | -250.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.40% | 10.03% | 491.45% | 149.92% | 449.71% |
| Repurchase of Common Stock | -1,400.00% | -1,400.00% | -400.00% | -540.00% | 60.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | 9.19% | 9.82% | 491.59% | 149.60% | 450.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.45% | -44.83% | 603.51% | 273.30% | 191.26% |